Champions Oncology Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 62.28. In total, the insiders bought 1 237 465 and sold 480 213 CSBR shares in the last 100 trades.

Insider Power

(Last 100 transactions)
62.28
Buy 1 237 465 Shares
Sell 480 213 Shares

Historical Insider Trades

Date Type Action Person Amount
Jan 12, 2024 Common Stock Buy Mendelson Daniel Newman 1 000
Jan 11, 2024 Common Stock Buy Mendelson Daniel Newman 2 000
Jan 10, 2024 Common Stock Buy Mendelson Daniel Newman 2 944
Jan 09, 2024 Common Stock Buy Mendelson Daniel Newman 3 000
Jan 08, 2024 Common Stock Buy Mendelson Daniel Newman 1 000
Jan 05, 2024 Common Stock Buy Mendelson Daniel Newman 2 000
Jan 04, 2024 Common Stock Buy Mendelson Daniel Newman 3 000
Jan 03, 2024 Common Stock Buy Mendelson Daniel Newman 500
Dec 21, 2023 Common Stock Buy Mendelson Daniel Newman 2 500
Dec 20, 2023 Common Stock Buy Mendelson Daniel Newman 2 100
Dec 19, 2023 Common Stock Buy Mendelson Daniel Newman 5 000
Nov 03, 2023 Option to purchase Common Stock Buy Tobin Scott R 28 600
Nov 03, 2023 Option to purchase Common Stock Buy Ackerman Joel 35 750
Nov 03, 2023 Option to purchase Common Stock Buy Mendelson Daniel Newman 26 220
Nov 03, 2023 Option to purchase Common Stock Buy Sidransky David 15 495
Nov 03, 2023 Option to purchase Common Stock Buy Breitfeld Philip P. 15 495
Oct 17, 2023 Common Stock Buy Ackerman Joel 114 552
Oct 17, 2023 Option to purchase Common Stock Sell Ackerman Joel 14 552
Oct 11, 2023 Common Stock Buy Mendelson Daniel Newman 5 000
Oct 10, 2023 Common Stock Buy Mendelson Daniel Newman 1 100
Oct 09, 2023 Option to purchase Common Stock Buy Davis Brady 68 000
Oct 09, 2023 Option to purchase Common Stock Buy Davis Brady 7 500
Oct 09, 2023 Option to purchase Common Stock Buy Davis Brady 135 000
Oct 06, 2023 Common Stock Buy Mendelson Daniel Newman 1 530
Oct 05, 2023 Common Stock Buy Mendelson Daniel Newman 2 000
Click to get the best stock tips daily for free!

About Champions Oncology

Champions Oncology Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Technology Platform, provides Personalized cancer care based upon the implantation of human tumors in immune... CSBR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT